Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01932294 · ClinicalTrials.gov registry record
Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support
A clinical trial of Heart Failure and Systolic Heart Failure, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- Completed
- Registry status
- 171
- Enrollment target
- 11
- Study locations
NCT01932294: Completed study of Heart Failure and Systolic Heart Failure, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
NCT01932294 is a study of Heart Failure and Systolic Heart Failure that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 171 participants, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower). The trial reports 11 study locations across 10 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01932294, a study of Heart Failure and Systolic Heart Failure, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).
- COMPLETED
- Registry status
- 171 participants
- Enrollment target
- 11
- Study locations
Study Summary
Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support program. Medamacs is funded through the Interagency for Mechanically Assisted Circulatory Support (INTERMACS) NHLBI Contract.
Primary Outcome
Death after the baseline visit up to 24 months
Conditions Studied
Study Locations (11)
Pennsylvania
- University of Pennsylvania - Philadelphia
- University of Pittsburgh - Pittsburgh
Alabama
- University of Alabama at Birmingham - Birmingham
California
- Cedars Sinai Medical Center - Beverly Hills
Colorado
- University of Colorado - Aurora
Iowa
- University of Iowa Hospitals and Clinics - Iowa City
Massachusetts
- Brigham and Women's Hospital - Boston
Michigan
- University of Michigan - Ann Arbor
North Carolina
- Duke University - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 171 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-01-20 |
What the finished NCT01932294 record still lists
NCT01932294 is an observational study that tracks outcomes without assigning an intervention. The registered 171 participants enrollment target is mid-sized for trials with a published cap, below the 2,049-participant average among 397 other Heart Failure trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Heart Failure appearing as the primary indexed condition, and to 0 interventions.
NCT01932294 lists 11 locations in 10 states (Pennsylvania, Alabama, California).
Frequently Asked Questions
What is clinical trial NCT01932294 about?
NCT01932294 is a clinical study titled "Medical Arm of the Interagency Registry for Mechanically Assisted Circulatory Support". Medamacs is a prospective, observational study of ambulatory patients with advanced heart failure. The study enrolls patients who have not yet received a Left Ventricular Assist Device (LVAD) but who receive their care at a hospital with a Joint Commission certified mechanical circulatory support pr...
What is the current status of trial NCT01932294?
This trial is currently completed. The enrollment target is 171 participants. The study started on 2013-04. Estimated completion is 2017-01-20.
What conditions does trial NCT01932294 study?
This clinical trial studies the following conditions: Heart Failure, Systolic Heart Failure.
Who is sponsoring clinical trial NCT01932294?
This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01932294 being conducted?
This trial has 11 study locations across Alabama, California, Colorado, Iowa, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Heart Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT01932294's enrollment target sits among peer trials
171 181st of 397 higher than 217 of 397 other Heart Failure trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Heart Failure trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Feasibility Study of the NORM™ System in Heart Failure Patients (FUTURE-HFII)
RECRUITING · NA
-
Diuretics Alone vs. Aortix Endovascular Device for Acute Heart Failure
RECRUITING · NA
-
iCardia4HF: Multi-component mHealth Intervention for Patients With Heart Failure
RECRUITING · NA
-
A Study to Evaluate Finerenone on Clinical Efficacy and Safety in Patients with Heart Failure Who Are Intolerant or Not Eligible for Treatment with Steroidal Mineralocorticoid Receptor Antagonists
RECRUITING · Phase 3
-
Circulating Markers That Underlie the Transition From Compensated Hypertrophy to Heart Failure
RECRUITING
-
Integration of Telemedicine and Home-Based Cardiac Rehabilitation: Feasibility, Efficacy, and Adherence
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02641145 · 171 participants · NA
Molecular Imaging of Primary Amyloid Cardiomyopathy
- NCT05541029 · 171 participants · NA
Music Listening: A Mechanistic Trial
- NCT05561127 · 171 participants · Phase 3
Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Bowel
- NCT05592938 · 171 participants · NA
Partial Breast Re-irradiation Using Ultra Hypofractionation (PRESERVE)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia